Applications Open for One North Carolina Small Business Program Grants
Raleigh-Durham News

Applications Open for One North Carolina Small Business Program Grants

Alcove Team | 11/17/23
The One North Carolina Small Business Program is now accepting applications for grants that provide crucial support to emerging technology companies in North Carolina.
Mastering the Sprint: Achieving Goals with Short, Intense Efforts
Raleigh-Durham News

Mastering the Sprint: Achieving Goals with Short, Intense Efforts

Alcove Team | 11/17/23
Learn how to rewire your norms and achieve your goals by embracing the power of sprints, short bursts of intense effort that yield tangible results.
Record Ridership on NC By Train: Governor Cooper Highlights Success and Future Investments
Raleigh-Durham News

Record Ridership on NC By Train: Governor Cooper Highlights Success and Future Investments

Alcove Team | 11/17/23
Governor Roy Cooper, along with state transportation officials, celebrated the record ridership on the NC By Train service between Raleigh and Charlotte. The governor also announced plans to invest in modernizing the state-owned passenger trains and potentially expanding routes within North Carolina.
One North Carolina Small Business Program: Grants Available for Emerging Tech Companies
Raleigh-Durham News

One North Carolina Small Business Program: Grants Available for Emerging Tech Companies

Alcove Team | 11/16/23
The One North Carolina Small Business Program is accepting applications for grants that provide capital to support the growth of emerging technology companies in the state.
Toyota Camry Goes Hybrid-Only: A Big Step for Mainstream Sedans
Raleigh-Durham News

Toyota Camry Goes Hybrid-Only: A Big Step for Mainstream Sedans

Alcove Team | 11/16/23
The best-selling car in America, the Toyota Camry, will be offered only as a hybrid car starting with the redesigned 2025 model.
Propella Therapeutics Acquired by Astella Pharma in $175 Million Deal
Raleigh-Durham News

Propella Therapeutics Acquired by Astella Pharma in $175 Million Deal

Alcove Tean | 11/16/23
Startup biotech Propella Therapeutics, known for its development of a prostate cancer treatment, is being acquired by Astella Pharma for $175 million.
. . .
. . .